Wenger Vieli has advised Swiss Fintech neon on its latest crowd investing campaign and financing round. Neon is an up-and-coming Swiss fintech that has been serving as many as over 130,000 clients already. The company was
Tags :Wenger Vieli
Wenger Vieli has advised and assisted CONET Technologies, a portfolio company of IK Partners, in all Swiss legal aspects in connection with the acquisition of emineo, a Swiss IT consulting and software engineering company, with
Wenger Vieli has advised the technology start-up Adresta on all Swiss tax and legal matters during the sale to the Lucerne-based Bucherer. The blockchain start-up Adresta, which is based in Technopark Zurich, will be fully
Wenger Vieli has advised NLS Pharmaceutics on a USD 4m private placement and conversion of existing short-term notes of USD 1.53m. NLS Pharmaceutics is a Swiss clinical-stage biopharmaceutical company focused on the discovery and development
Avelo, a Schlieren-based start-up, has just closed its oversubscribed seed financing round of CHF 2.2 Mio. to accelerate the clinical validation of their breath collector in order to make a difference in the fight against Tuberculosis
Wenger Vieli has acted as Swiss legal counsel of Verium on the closing of its first continuation vehicle Verium I SCSp regarding Toradex Group and MiT Energie Holding at CHF 120 million. Verium I SCSp was
Wenger Vieli has advised the shareholders of the Swiss startup company CTsystems, a highly-specialized engineering company, on its sale to Datwyler, a specialist for system-critical elastomer components, on all legal and tax aspects. As we
Wenger Vieli has advised the French impact fund STOA Infra & Energy as lead investor on all Swiss legal aspects in connection with the Series B financing round of candi solar, a clean energy company
Lukas Groth returns as a lawyer, specifically as an associate, at Wenger Vieli Zurich’s office. Groth’s practice focuses primarily on the area of litigation before state courts and arbitration tribunals. Lukas Groth has
Wenger Vieli has acted as legal advisor to Xeltis, a clinical-stage company developing medical devices enabling cardiovascular restoration, on securing EUR 15 million in equity and license fees from the lead investor as cornerstone funding in
